Impact of guidance from a computer-aided multispectral digital skin lesion analysis device on decision to biopsy lesions clinically suggestive of melanoma.

tech, Novartis, and Pfizer, receiving grants and honoraria; he was a consultant with Celgene, Covance, Galderma, Shire Pharmaceuticals, and Wyeth, receiving honoraria; and he was an investigator with Shionogi, receiving grants. Funding/Support: This study was supported by grant RC1-AR058204 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (Dr Gelfand), Training Grant T32-AR07465 from the National Institutes of Health (Ms Wan and Mr Shin), and the Doris Duke Clinical Research Fellowship (Dr Abuabara). Role of the Sponsors: The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of data; or in the preparation, review, or approval of the manuscript.